Symbiosis C.M.
PrivateLast Round
Grant
Oct 29, 2024
Total Funding Raised
$4.1M
Company Overview
Symbiosis C.M. is a medical device company that develops adaptive transcatheter heart valve technology for the treatment of mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiosis C.M. Comparables
Compare Symbiosis C.M. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tioga Cardiovascular | 86% | |
| ReValve Solutions | 83% | |
| 4C Medical Technologies, Inc. | 83% |
Symbiosis C.M. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 29, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Seed | Dec 1, 2023 | ||||
| Pre Seed | Jan 1, 2023 | ||||
| Grant | Jul 22, 2022 | ||||
Angel | Jan 1, 2022 |
Symbiosis C.M. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coller Capital | Grant |
| Israel Innovation Authority | Grant, Angel |
| The Jon DeHaan Foundation | Grant |
| Jeremy Coller Foundation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Grew 21% QoQ from 14 to 17 employees.
- Feb 25, 2025
Grew 56% QoQ, from 9 to 14 employees.
Symbiosis C.M. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Symbiosis C.M.'s valuation, stock price, and market status.
Is Symbiosis C.M. a public or private company?
Symbiosis C.M. is a private company.
What is the current stock price of Symbiosis C.M.?
Symbiosis C.M. is a private company, so its shares have no public market price. Caplight tracks Symbiosis C.M.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symbiosis C.M. worth (valuation)?
Valuation information for Symbiosis C.M. is not publicly available.
Can I buy Symbiosis C.M. stock?
Symbiosis C.M. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symbiosis C.M.'s last funding round?
Symbiosis C.M.'s most recent funding round was Grant on October 29, 2024.
Who are the main investors in Symbiosis C.M.?
Key investors in Symbiosis C.M. include Coller Capital, Israel Innovation Authority, The Jon DeHaan Foundation, Jeremy Coller Foundation.
Will Symbiosis C.M. IPO soon?
No public IPO plans have been announced for Symbiosis C.M..
How can I track Symbiosis C.M. secondary market activity?
Caplight tracks bids, offers, and trades in Symbiosis C.M.'s shares on secondary markets.